Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies
about
Association of common variation in the PPARA gene with incident myocardial infarction in individuals with type 2 diabetes: a Go-DARTS studyToday's guidanceNoninvasive Cardiovascular Risk Assessment of the Asymptomatic Diabetic Patient: The Imaging Council of the American College of CardiologyThe obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitusDiabetes mellitus and mortality after acute coronary syndrome as a first or recurrent cardiovascular event.Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).Should all diabetic patients be treated with a statin?Effective diabetes care: a need for realistic targets.Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by represLong-term cardiovascular risk in type 2 diabetic compared with nondiabetic first acute myocardial infarction patients: a population-based cohort study in southern Europe.Metabolic syndrome predicts vascular changes in whole body magnetic resonance imaging in patients with long standing diabetes mellitusSubclinical cardiovascular disease in type 2 diabetes mellitus: To screen or not to screen.Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a Middle East population.Obesity, glucose intolerance and diabetes and their links to cardiovascular disease. Implications for laboratory medicine.The bitter fate of the sweet heart: impairment of iron homeostasis in diabetic heart leads to failure in myocardial protection by preconditioning.Diabetes and coronary heart disease as risk factors for mortality in older adults.Statins in the era of evidence-based medicine--who will not "prosper"?Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease.The Population-Based Risk of Need for Coronary Revascularization According to the Presence of Type 2 Diabetes Mellitus and History of Coronary Heart Disease in the Korean Population.Should we routinely measure a proxy for insulin resistance as well as improve our modelling techniques to better predict the likelihood of coronary heart disease in people with type 2 diabetes? For debate.Measures of global risk: old versus new methods.Why are we getting myocardial infarction? Because our genes date from the last Ice Age. The global cardiovascular risk.The association of self-reported coronary heart disease with diabetes duration in Korea.Mortality associated with diabetes and cardiovascular disease in older women.Practical aspects of the control of cardiovascular risk in type 2 diabetes mellitus and the metabolic syndrome.Prevention of cardiovascular disease guided by total risk estimations--challenges and opportunities for practical implementation: highlights of a CardioVascular Clinical Trialists (CVCT) Workshop of the ESC Working Group on CardioVascular PharmacoloValidity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study.Diabetes and the heart: could the diabetic myocardium be protected by preconditioning?The burden of hyperlipidaemia and diabetes in cardiovascular diseases.Comparison of prognosis for men with type 2 diabetes mellitus and men with cardiovascular disease.Coronary artery calcium screening in persons with metabolic syndrome and diabetes: implications for preventionManagement of cardiorenal metabolic syndrome in diabetes mellitus: a phytotherapeutic perspectiveLipid control in patients with diabetes mellitus.Revisiting the links between glycaemia, diabetes and cardiovascular disease.Role of coronary artery calcium in cardiovascular risk assessment.Imaging Atherosclerosis in Diabetes: Current State.Glycation and cardiovascular disease in diabetes: A perspective on the concept of metabolic memory.HbA1c in type 2 diabetes diagnostic criteria: addressing the right questions to move the field forwards.
P2860
Q24813954-3456A121-9426-444E-8783-6F8898E342D7Q28211142-0C3EC644-23F6-4B4B-B5E5-C29E9A110ACDQ30277401-1ED0CB67-8345-464E-B6CD-ECA455236783Q30379006-D2BC17FC-9CD9-4495-9D4C-22F7D576DF59Q33378481-633E9902-DBFE-497A-A57B-4B106AD378E4Q33404972-3638D348-C05F-48E1-9F9F-0A42E6CFF1EEQ33610801-ABCA619D-1577-4EBF-AAF5-26B0F182A364Q33811016-EE86DCAA-CD26-4F92-B470-8B49E7560D18Q34023548-2BE9B46A-9CBF-481D-B63F-EB6C9128E05AQ34046881-6526147C-10B5-4571-BA86-CBB8A8D25465Q34084551-705306E8-CD81-4C01-811F-4EE90F56638BQ34114369-E2A7CCCD-7C0D-4C0C-9F14-48467CF456DFQ34179368-046BB566-C4ED-4BBB-AC25-3CFE8567DEE8Q34299778-626FC4C5-B239-4432-A0B7-A675BE822511Q34468205-6D4E3195-E753-4E1E-8956-56DE679984C8Q34543079-5FC212DE-D3C3-4FE6-9539-A6E0C46BC3ABQ34729946-FF966D53-0B32-480E-828F-1C14A04268BFQ35134400-A2CC0965-434A-485E-8B48-07AB1C406E60Q35216631-0D2F7CAA-33A2-42A8-BE36-C6213DED0654Q35583188-C27FC25C-ADE8-45CE-9FAF-57DB417A6EAEQ35656400-284A821E-2E83-43A8-8D4A-B6A8C3CDEEE6Q35788919-EA0E4A67-E4AF-4451-8AE0-4954E3813DD4Q36035823-0CBD1575-C2B6-4DD6-B162-0B7BEE4E6C78Q36362599-7C1117BF-56F0-46D3-9149-EEB478D13ECCQ36365230-DF406A46-E81C-439A-967B-BE374BDC200CQ36380616-FE723BE1-3824-40C9-9498-2118E7E69F2EQ36608406-CDA6E105-567B-4E72-8559-5C1263A4A4ADQ36613362-D80135EF-F18C-4CA9-9F91-DD04B23E1B59Q36768750-E39CC012-6914-4183-A97B-FE0883679430Q36981806-0ACD440A-0E5A-420E-946B-7C5CB90C8AE3Q37000773-F1D59F93-E896-4367-91F5-A447646E4147Q37032603-5C1D858E-E2FE-4D3C-AD0D-6C2A81F1A23AQ37342812-13C0D1C9-DB12-4584-B79D-7A42DC998DD1Q37730653-C115A3CA-4BB6-435E-872D-92C3469C5F89Q37853015-2C41E55E-147E-4523-A256-0760C7523F57Q38077060-E4441DBC-7E03-4B87-8524-28F87A8BC778Q38171865-499CA768-ACAE-4246-82EC-F83BD511C911Q38818605-CE46DF1F-AB58-40E5-AA6C-CE359F13A860Q38936100-83F32C2E-226C-4666-86A8-609CFC40A2AEQ39643656-94B1062B-9089-40B3-B586-AF252FEA87E9
P2860
Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Comparison of cardiovascular r ...... s sectional and cohort studies
@ast
Comparison of cardiovascular r ...... s sectional and cohort studies
@en
type
label
Comparison of cardiovascular r ...... s sectional and cohort studies
@ast
Comparison of cardiovascular r ...... s sectional and cohort studies
@en
prefLabel
Comparison of cardiovascular r ...... s sectional and cohort studies
@ast
Comparison of cardiovascular r ...... s sectional and cohort studies
@en
P2093
P2860
P921
P356
P1433
P1476
Comparison of cardiovascular r ...... s sectional and cohort studies
@en
P2093
Andrew D Morris
Jixian Wang
Josie M M Evans
P2860
P304
P356
10.1136/BMJ.324.7343.939
P407
P577
2002-04-01T00:00:00Z